业务描述
|
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
|